AURO-LOSARTAN HCT 12.5 MG
HYDROCHLOROTHIAZIDE : 12.5 MG LOSARTAN POTASSIUM : 100 MG · DIN 02423650 · AURO PHARMA INC
Health Canada status: MARKETED
What is AURO-LOSARTAN HCT?
AURO-LOSARTAN HCT 12.5 MG contains HYDROCHLOROTHIAZIDE : 12.5 MG LOSARTAN POTASSIUM : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02423650, held by AURO PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-Apr-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AURO-LOSARTAN HCT used for?
AURO - LOSARTAN HCT (Losartan Potassium and Hydrochlorothiazide Tablets) is indicated for the treatment of essential hypertension in patients for whom combination therapy is appropriate. AURO - LOSARTAN HCT is not indicated as the initial therapy for essential hypertension, except in patients with severe essential hypertension (Sitting DBP ≥110 mmHg) for whom the benefit of a prompt blood pressure reduction exceeds the risk of initiating combination therapy in these patients.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02423650 |
|---|---|
| Brand name | AURO-LOSARTAN HCT |
| Generic / active ingredient | HYDROCHLOROTHIAZIDE : 12.5 MG LOSARTAN POTASSIUM : 100 MG |
| Manufacturer | AURO PHARMA INC |
| Strength | 12.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09DA01 LOSARTAN AND DIURETICS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Apr-2014 |
How is it stored and handled?
null
How is it supplied?
Blister Pack of 3 x 10’s count, HDPE Pack of 14’s, 30’s, 100’s & 500’s count.
Is LOSARTAN AND DIURETICS in shortage in Canada?
A Canadian shortage report is on file for this molecule: Resolved — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C09DA01 LOSARTAN AND DIURETICS. 21 of 53 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-LOSARTAN HCT | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02423669 |
| AURO-LOSARTAN HCT | 50 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02423642 |
| HYZAAR | 100 MG | TABLET | ORGANON CANADA INC. | MARKETED | DIN 02297841 |
| HYZAAR | 50 MG | TABLET | ORGANON CANADA INC. | MARKETED | DIN 02230047 |
| HYZAAR DS | 100 MG | TABLET | ORGANON CANADA INC. | MARKETED | DIN 02241007 |
| LOSARTAN HCT | 100 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02388979 |
| LOSARTAN HCT | 50 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02388960 |
| LOSARTAN HCT DS | 25 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02388987 |
| LOSARTAN/HCTZ | 12.5 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02427656 |
| LOSARTAN/HCTZ | 25 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02427664 |
Who else supplies LOSARTAN AND DIURETICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LOSARTAN AND DIURETICS appears in 4256 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.